staphylokinase
Biologicalexperimental
Clinical trial activity
8 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
5
Phase 4
3
Earliest trial started Oct 1, 2010 (NCT01305226)
Timeline
Indications
Approved for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- thr-100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06362746 | Phase 3 | May 23, 2024 | Government of Russia, Supergene, LLC |
| NCT05410925 | Phase 4 | Jan 1, 2023 | Nanjing Medical University |
| NCT05372718 | Phase 3 | Dec 1, 2022 | Government of Russia, Supergene, LLC |
| NCT05135546 | Phase 2/Phase 3 (Phase 3) | Dec 1, 2021 | Russian Academy of Medical Sciences, Supergene, LLC |
| NCT05649696 | Phase 4 | Oct 29, 2021 | Nanjing Medical University |
| NCT05023681 | Phase 4 | Sep 1, 2021 | Nanjing Medical University |
| NCT04688320 | Phase 3 | Dec 15, 2020 | Pirogov Russian National Research Medical University, Supergene, LLC |
| NCT01305226 | Phase 3 | Oct 1, 2010 | Bharat Biotech International Limited |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Supergene, LLC | For profit | 4 | 4 | 1 | 2020 |
| Nanjing Medical University | Academic/Hospital | 3 | 3 | 1 | 2021 |
| Government of Russia | Government | 2 | 0 | 1 | 2022 |
| Bharat Biotech International Limited | For profit | 1 | 1 | 1 | 2010 |
| Pirogov Russian National Research Medical University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Russian Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2021 |
6 organizations
Page 1 / 1